Citadel Advisors’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.07M | Buy |
216,136
+119,854
| +124% | +$1.15M | ﹤0.01% | 2659 |
|
2025
Q1 | $895K | Buy |
96,282
+40,695
| +73% | +$378K | ﹤0.01% | 3396 |
|
2024
Q4 | $773K | Buy |
55,587
+31,635
| +132% | +$440K | ﹤0.01% | 3522 |
|
2024
Q3 | $563K | Buy |
+23,952
| New | +$563K | ﹤0.01% | 3674 |
|
2024
Q2 | – | Sell |
-16,789
| Closed | -$275K | – | 6836 |
|
2024
Q1 | $275K | Buy |
+16,789
| New | +$275K | ﹤0.01% | 4490 |
|
2023
Q1 | – | Sell |
-26,717
| Closed | -$203K | – | 6581 |
|
2022
Q4 | $203K | Sell |
26,717
-13,902
| -34% | -$106K | ﹤0.01% | 4689 |
|
2022
Q3 | $357K | Sell |
40,619
-34,226
| -46% | -$301K | ﹤0.01% | 4392 |
|
2022
Q2 | $535K | Sell |
74,845
-3,464
| -4% | -$24.8K | ﹤0.01% | 4069 |
|
2022
Q1 | $838K | Sell |
78,309
-4
| -0% | -$43 | ﹤0.01% | 3918 |
|
2021
Q4 | $1.1M | Buy |
+78,313
| New | +$1.1M | ﹤0.01% | 3712 |
|